Antibodies

Items 161-170 of 243

per page
Set Descending Direction
  1. anti-NQO1 (human), pAb
    AG-25A-0105
    AG-25A-0105-C100100 µg
    CHF 190.00
    Western blot analysis using anti-NQO1 (human), pAb (Prod. No. AG-25A-0105) at 1:2'000 dilution.
1: Human NQO1 (His-tagged).
2: HepG2 cell lysate.
3: Unrelated protein (His-tagged) (negative control).
  2. anti-PARP-1 [ARTD1] (human), pAb
    AG-25T-0002
    AG-25T-0002-R100100 µl
    CHF 280.00
  3. anti-PARP-1 [ARTD1] (mouse), pAb
    AG-25T-0001
    AG-25T-0001-R100100 µl
    CHF 340.00
  4. anti-PARP-10 [ARTD10] (human), mAb (5H11)
    AG-20T-0004
    AG-20T-0004-L0011 ml
    CHF 380.00
    Immunofluorescence using anti-PARP-10 [ARTD10] (human), mAb (5H11). Method: T47D mammary carcinoma cells were stained by indirect immunofluorescence and analysed. Prior to fixation and staining, the cells were treated with or without 50nm leptomyci
  5. anti-PARP-2 [ARTD2] (mouse), pAb
    AG-25T-0003
    AG-25T-0003-R100100 µl
    CHF 350.00
  6. anti-PD-1 (human), mAb (AG-IHC001)
    AG-20B-6020
    AG-20B-6020-R100100 µl
    CHF 150.00
    PD-1 receptor-induced CD4 T cell activation and proliferation by PD-1 (mouse), mAb (blocking) (1H10) (AG-20B-0075).Method: Magnetic bead affinity purified CD4+ T cells from C57BL/6 mice are stimulated in vitro with PD-1 (mouse), mAb (b
  7. anti-PD-1 (mouse), mAb (blocking) (1H10)
    AG-20B-0075
    AG-20B-0075-C100100 µg
    CHF 230.00
    anti-BAFF (mouse), mAb (Sandy-2) (Prod. No. AG-20B-0063) blocks the action of endogenous BAFF in vivo.  Method: Wild type C57BL/6 mice were treated at day 0 (single administration) with monoclonal antibody anti-BAFF (mouse), mAb (Sandy
  8. anti-PD-1 (mouse), mAb (blocking) (1H10) (preservative free)
    AG-20B-0075PF
    AG-20B-0075PF-C100100 µg
    CHF 230.00
    AG-20B-0075PF-C500500 µg
    CHF 400.00
    AG-20B-0075PF-M0022 mg
    CHF 590.00
    anti-BAFF (mouse), mAb (Sandy-2) (Prod. No. AG-20B-0063) blocks the action of endogenous BAFF in vivo.  Method: Wild type C57BL/6 mice were treated at day 0 (single administration) with monoclonal antibody anti-BAFF (mouse), mAb (Sandy
  9. anti-PD-L1 (human), mAb (AG-IHC411)
    AG-20B-6022
    AG-20B-6022-R100100 µl
    CHF 200.00
    PD-1 receptor-induced CD4 T cell activation and proliferation by PD-1 (mouse), mAb (blocking) (1H10) (AG-20B-0075).Method: Magnetic bead affinity purified CD4+ T cells from C57BL/6 mice are stimulated in vitro with PD-1 (mouse), mAb (b
  10. anti-Periostin, mAb (blocking) (OC-20) (preservative free)
    AG-20B-6000YPF
    AG-20B-6000YPF-C100100 µg
    CHF 470.00
    AG-20B-6000YPF-C500500 µg
    CHF 1'900.00

    Replaces AG-20B-6000PF

    anti-Periostin, mAb (blocking) (OC-20) (preservative free)

Items 161-170 of 243

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.